Aug 3, 2021
August 03, 2021 07:00 AM Eastern Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, Inc., a company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that John...
Jul 1, 2021
VANCOUVER, Wash., June 30, 2021 /PRNewswire/ — Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced today that it has filed a registration statement on Form S-1 with the U.S....
Jun 15, 2021
AUSTIN, Texas, June 15, 2021 /PRNewswire/ — SciBite and L7 Informatics are pleased to announce a partnership that enables L7 Informatics to deliver ontology management powered by SciBite’s CENtree™ software within L7’s Enterprise Science Platform...
Jun 2, 2021
June 1, 2021 /NewsDesk/ Research services firm Charles River Laboratories (CRL) states that its fast-growing manufacturing business uses a technology-agnostic strategy built around innovation and flexibility. Since its founding in the late 1940s, CRLs have primarily...
Mar 25, 2021
Two months after acquiring an AI engine it claims can potentially speed up drug development by “unprecedented” levels,” AbSci has secured a hefty crossover round to integrate the engine into the company. And it has CEO Sean McClain considering an eventual IPO. AbSci...
Mar 25, 2021
Round was co-led by Casdin Capital and Redmile Group Fidelity Management & Research Company LLC, D1 Capital Partners, and Perceptive Advisors are among the new investors. VANCOUVER, Wash., March 23, 2021 /PRNewswire/ — AbSci, a pioneering synthetic biology...
